Total Payments
$1,975
2024 Payments
$156.57
Companies
16
Transactions
49
Medicare Patients
572
Medicare Billing
$52,404
Payment Breakdown by Category
Travel$1,020 (51.6%)
Food & Beverage$939.67 (47.6%)
Education$15.52 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,020 | 5 | 51.6% |
| Food and Beverage | $939.67 | 43 | 47.6% |
| Education | $15.52 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $1,210 | 10 | $0 (2017) |
| Astellas Pharma US Inc | $282.07 | 20 | $0 (2020) |
| Pfizer Inc. | $121.93 | 1 | $0 (2020) |
| ABBVIE INC. | $69.38 | 3 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $45.30 | 2 | $0 (2024) |
| Laborie Medical Technologies Corp. | $43.96 | 1 | $0 (2024) |
| Boston Scientific Corporation | $38.90 | 2 | $0 (2019) |
| Antares Pharma, Inc. | $32.14 | 2 | $0 (2020) |
| Medtronic USA, Inc. | $20.47 | 1 | $0 (2018) |
| PRN Medical Services, LLC | $18.97 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.57 | 6 | ABBVIE INC. ($50.29) |
| 2020 | $195.85 | 6 | Pfizer Inc. ($121.93) |
| 2019 | $170.33 | 12 | Astellas Pharma US Inc ($120.63) |
| 2018 | $192.70 | 12 | Astellas Pharma US Inc ($105.41) |
| 2017 | $1,260 | 13 | Intuitive Surgical, Inc. ($1,210) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: UROLOGY | ||||||
| 03/24/2024 | Laborie Medical Technologies Corp. | Urgent PC Neuromodulation System (Device) | Food and Beverage | Cash or cash equivalent | $43.96 | General |
| Category: Urology | ||||||
| 03/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: UROLOGY | ||||||
| 02/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: DIABETES | ||||||
| 10/08/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: ONCOLOGY | ||||||
| 03/19/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Rheumatoid Arthritis | ||||||
| 03/09/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: UROLOGY | ||||||
| 01/29/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Rheumatoid Arthritis | ||||||
| 01/22/2020 | Pfizer Inc. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $121.93 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: UROLOGY | ||||||
| 10/23/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: UROLOGY | ||||||
| 08/22/2019 | KARL STORZ Endoscopy-America | URETERO-RENO-FIBERSCOPE FLEX-X (Device) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: UROLOGY | ||||||
| 08/21/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PROSTATE HEALTH | ||||||
| 05/30/2019 | Boston Scientific Corporation | ADVANTAGE (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: PELVIC ORGAN PROLAPSE | ||||||
| 05/29/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: UROLOGY | ||||||
| 12/13/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 295 | 331 | $143,166 | $34,513 |
| 2021 | 2 | 39 | 42 | $12,402 | $3,277 |
| 2020 | 11 | 238 | 274 | $57,016 | $14,614 |
Total Patients
572
Total Services
647
Medicare Billing
$52,404
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 137 | 137 | $56,444 | $16,913 | 30.0% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 14 | 14 | $48,720 | $7,162 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 77 | $13,860 | $5,154 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 32 | $8,512 | $2,857 | 33.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 12 | 12 | $5,025 | $1,117 | 22.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 16 | 16 | $8,816 | $953.64 | 10.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 23 | 28 | $1,204 | $205.62 | 17.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 14 | 15 | $585.00 | $151.06 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 23 | $5,543 | $1,817 | 32.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,859 | $1,460 | 21.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $11,191 | $4,025 | 36.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 38 | $9,563 | $3,181 | 33.3% |
| 51728 | Insertion of electronic device into bladder with voiding pressure studies | Office | 2020 | 12 | 12 | $9,720 | $2,488 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 54 | $10,430 | $1,945 | 18.7% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2020 | 12 | 12 | $3,444 | $1,277 | 37.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 15 | 15 | $2,924 | $582.13 | 19.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 17 | $1,938 | $502.01 | 25.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2020 | 12 | 12 | $5,952 | $276.00 | 4.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 41 | 55 | $550.00 | $180.73 | 32.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 14 | 16 | $800.00 | $96.72 | 12.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 12 | 12 | $504.00 | $60.30 | 12.0% |
About Dr. Serge Marinkovic, MD
Dr. Serge Marinkovic, MD is a Plastic and Reconstructive Surgery healthcare provider based in Galesburg, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093705501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Serge Marinkovic, MD has received a total of $1,975 in payments from pharmaceutical and medical device companies, with $156.57 received in 2024. These payments were reported across 49 transactions from 16 companies. The most common payment nature is "Travel and Lodging" ($1,020).
As a Medicare-enrolled provider, Marinkovic has provided services to 572 Medicare beneficiaries, totaling 647 services with total Medicare billing of $52,404. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Plastic and Reconstructive Surgery
- Other Specialties Urology, Urology
- Location Galesburg, IL
- Active Since 10/26/2005
- Last Updated 07/31/2025
- Taxonomy Code 2086S0122X
- Entity Type Individual
- NPI Number 1093705501
Products in Payments
- Da Vinci Surgical System (Device) $1,210
- XTANDI (Drug) $337.10
- BOTOX (Biological) $66.18
- GEMTESA (Drug) $45.30
- Urgent PC Neuromodulation System (Device) $43.96
- MYRBETRIQ (Drug) $36.76
- OTREXUP (Drug) $32.14
- INTERSTIM (Device) $20.47
- REZUM (Device) $19.89
- Xtandi (Drug) $19.31
- Lupron (Drug) $19.09
- ADVANTAGE (Device) $19.01
- SELF-CATH (Device) $18.97
- ENSEAL Product Family (Device) $17.50
- Noctiva (Drug) $17.04
- JARDIANCE (Drug) $17.02
- ELIGARD (Drug) $13.31
- Myrbetriq (Drug) $10.83
- URETERO-RENO-FIBERSCOPE FLEX-X (Device) $10.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.